Sort
15,842 grants matching “pancreatic cancer”
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$485,683Kenneth P Olive · Columbia University Health Sciences · R01 · FY2024 · CA
A novel, glutathione-dependent metabolic pathway drives metastatic outgrowth in pancreatic cancer
$485,558Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2025 · CA
A novel, glutathione-dependent metabolic pathway drives metastatic outgrowth in pancreatic cancer
$485,558Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2024 · CA
Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer
$485,495Or P. Gozani · Stanford University · R01 · FY2020 · CA
Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation
$485,413Livia Schiavinato Eberlin · Baylor College Of Medicine · R33 · FY2021 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$485,131David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Developing new therapeutic strategies for distinct Ras-driven cancers
$485,105Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2021 · CA
Receptor-Targeted Fluorescence-Guided Surgery in Pancreatic Neuroendocrine Tumors
$485,072Ali Azhdarinia · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Integrating roles of noncoding RNPs in RNA biogenesis, RNA decay and cell survival
$485,016Christian Tschudi · Yale University · R01 · FY2016 · GM
The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling
$484,816Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2020 · CA
K-Ras sumoylation in cell proliferation and transformation
$484,800Wei Dai · New York University School Of Medicine · R01 · FY2021 · CA
Targeting the Unfolded Protein Response in PanNETs
$484,554Scott A Oakes · University Of Chicago · R01 · FY2022 · CA
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
$484,359Gail E Sonenshein · Tufts University Boston · R01 · FY2014 · CA
Administrative Core
$484,203Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS
$483,863Brigham And Women'S Hospital · R01 · FY2004 · CA
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
$483,852Mark R. Kelley · Indiana University Indianapolis · R01 · FY2022 · CA
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
$483,810Jason B Fleming · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
PDX Core
$483,808Bingliang Fang · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Gut pathogen virulence and its therapeutic modulation during surgical injury
$483,800John C. Alverdy · University Of Chicago · R01 · FY2022 · GM
Mechanisms of Signal Transduction by Ras Proteins
$483,712Dafna Bar-Sagi · New York University School Of Medicine · R56 · FY2009 · CA
Project 2: Combined CAR-T cell therapy
$483,710Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
FUNCTIONAL GENOMIC IDENTIFICATION AND CHARACTERIZATION OF THERAPEUTIC TARGETS
$483,631Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA